Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ecco-jcc/jjaa061 http://scihub22266oqcxt.onion/10.1093/ecco-jcc/jjaa061 32215548!7184365!32215548     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32215548.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Crohns+Colitis 2020 ; 14 (9): 1334-1336 Nephropedia Template TP {{tp|p=32215548|t=2020. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?|pdf=|usr=}}{{32215548}} gab.com Text Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection JO: J Crohns Colitis http://www.kidney.de/pget.php?&tw=1&pmid=32215548 #FOAvip Crohn's disease [CD] and ulcerative colitis [UC], the main inflammatory bowel diseases [IBD] in humans, are chronic, immune-inflammatory diseases, the pathogenesis of which suggests a complex interaction between environmental factors and genetic susceptibility. These disabling conditions affect millions of individuals and, together with the drugs used to treat them, can put patients at risk of developing complications and other conditions. This is particularly relevant today, as coronavirus disease [Covid-19] has rapidly spread from China to countries where IBD are more prevalent, and there is convincing evidence that Covid-19-mediated morbidity and mortality are higher in subjects with comorbidities. The primary objectives of this Viewpoint are to provide a focused overview of the factors and mechanisms by which the novel severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infects cells and to illustrate the link between such determinants and intestinal inflammation. We also provide clues about the reasons why the overall IBD population might have no increased risk of developing SARS-CoV-2 infection and highlight the potential of cytokine blockers, used to treat IBD patients, to prevent Covid-driven pneumonia. Twit Text FOAVip Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection ????J Crohns Colitis http://www.kidney.de/pget.php?&tw=1&pmid=32215548 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32215548 #FOAvip English Wikipedia <ref>{{Cite pmid|32215548}}</ref> Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection? #MMPMID32215548 Monteleone G; Ardizzone S J Crohns Colitis 2020[Sep]; 14 (9): 1334-1336 PMID32215548show ga Crohn's disease [CD] and ulcerative colitis [UC], the main inflammatory bowel diseases [IBD] in humans, are chronic, immune-inflammatory diseases, the pathogenesis of which suggests a complex interaction between environmental factors and genetic susceptibility. These disabling conditions affect millions of individuals and, together with the drugs used to treat them, can put patients at risk of developing complications and other conditions. This is particularly relevant today, as coronavirus disease [Covid-19] has rapidly spread from China to countries where IBD are more prevalent, and there is convincing evidence that Covid-19-mediated morbidity and mortality are higher in subjects with comorbidities. The primary objectives of this Viewpoint are to provide a focused overview of the factors and mechanisms by which the novel severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infects cells and to illustrate the link between such determinants and intestinal inflammation. We also provide clues about the reasons why the overall IBD population might have no increased risk of developing SARS-CoV-2 infection and highlight the potential of cytokine blockers, used to treat IBD patients, to prevent Covid-driven pneumonia. |*Colitis, Ulcerative/epidemiology/immunology/therapy[MESH] |*Coronavirus Infections/epidemiology/immunology/prevention & control[MESH] |*Crohn Disease/epidemiology/immunology/therapy[MESH] |*Pandemics/prevention & control[MESH] |*Pneumonia, Viral/epidemiology/immunology/prevention & control[MESH] |Betacoronavirus/physiology[MESH] |COVID-19[MESH] |Communicable Disease Control/methods[MESH] |Comorbidity[MESH] |Humans[MESH] |Prevalence[MESH] |Risk Assessment[MESH] |Risk Factors[MESH]Are Patients with Inflammatory Bowel Disease at Increased Risk for Cov(epmc).pdf DeepDyve Pubget Overpricing